It's anticipated that these new recommendations will be integrated into the NRP sometime in the Spring of 2006 and into the PALS program shortly thereafter. Considering the scope of changes in the new recommendations, pediatricians should make a point of taking revised training courses as soon as these become available. For a complete discussion of the new guidelines, visit http://www.americanheart.org/.
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.